BRIDGET FITZGIBBON: Open Payments
NPI 1679976187 · PROVIDENCE, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$959 in 23 payments from 9 companies in 2025. Trend: 2023 $554 · 2024 $789 · 2025 $959
Food & beverage: $959
| Company | Payments | Amount |
|---|---|---|
| Braintree Laboratories, Inc. | 4 | $347 |
| Janssen Biotech, Inc. | 3 | $161 |
| Azurity Pharmaceuticals, Inc. | 1 | $138 |
| Gilead Sciences, Inc. | 5 | $120 |
| ABBVIE INC. | 5 | $104 |
| Medtronic, Inc. | 1 | $34 |
| PFIZER INC. | 2 | $33 |
| Fresenius Kabi USA, LLC | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $7 |
Products named: SUFLAVE, TREMFYA, SKYRIZI, BARRX, VELSIPITY, LINZESS, CREON, Adalimumab-aacf.
Industry payments across RI — which companies pay providers there.
